Quantcast

Latest Molecular imaging Stories

2011-04-04 09:00:00

CULVER CITY, Calif., April 4, 2011 /PRNewswire/ -- Sofie Biosciences, a developer of molecular imaging systems and agents, announced the launch of GENISYS4, their new benchtop small animal PET system. Introduced today at the 2011 American Association for Cancer Research Annual Meeting, this compact, preclinical multimodality PET system provides researchers with the ability to non-invasively visualize and measure the biology of disease and therapeutic response over the course of a study....

2011-03-22 10:09:00

BIRMINGHAM, Ala. and SHREVEPORT, La., March 22, 2011 /PRNewswire-USNewswire/ -- Southern Research Institute today announced that it has signed a services agreement with the Biomedical Research Foundation of Northwest Louisiana that will provide commercial non-invasive preclinical imaging services exclusively for the Birmingham-based not-for-profit scientific research center. The Biomedical Research Foundation will provide radiopharmaceuticals, radiochemistry and radiopharmacy expertise,...

2011-03-17 07:00:00

LAS VEGAS, March 17, 2011 /PRNewswire/ -- A new study by Craig Thiessen, M.D., Director of Radiology for West Houston Radiology L.L.P. and North Cypress Medical Center in Houston, presented this week at the National Consortium of Breast Centers Annual Meeting, found the improved photon sensitivity of new detector technologies such as PSPMTs and CZT should be capable of reducing the radiation dose patient receive from BSGI/MBI studies by 75%. However, low dose imaging is currently an...

2011-03-02 07:30:00

VIENNA, March 2, 2011 /PRNewswire/ -- Naviscan, Inc., announces the European launch of the Naviscan Positron Emission Mammography (PEM) scanner at two prestigious radiology conferences in Vienna. On March 3rd, at the European Society of Breast Imaging (EUSOBI) Annual Scientific Meeting, a podium presentation will focus on recently published PEM (Positron Emission Mammography) data demonstrating PEM's ability to reduce unnecessary biopsies by providing superior specificity, the ability to...

2011-02-24 07:30:00

SAN DIEGO, Feb. 24, 2011 /PRNewswire/ -- Naviscan, Inc. announced that it has entered into an exclusive licensing agreement with Neoprobe Corporation (NYSE Amex: NEOP) as a partner to further develop its patented imaging technology. While most of the patents in Naviscan's extensive intellectual property portfolio were designed to enable innovation in organ-specific molecular imaging, several more recently-allowed patents were devised to further broaden the company's product base. One...

2011-02-01 23:40:25

Positron emission tomography (PET) can image metabolic changes following treatment with the protein kinase inhibitor vandetanib, helping to define the therapy response or the effectiveness of the therapeutic agent, according to research published in the February issue of The Journal of Nuclear Medicine. Currently being tested in clinical trials, vandetanib inhibits the function of the RET (rearranged-during-transfection protein) proto-oncogene and other protein kinases involved in the...

2011-01-11 14:17:59

A group of researchers at Universidad Carlos III de Madrid (UC3M) have designed and developed a biomedical scanner that detects cellular processes at the molecular level and indicates malfunctioning of an organ before said malfunction can produce an anatomical change. The work carried out by these scientists has ranged from the initial design of an electronic architecture for gamma ray detectors to industry transfer of a complete scanner, after having adequately validated a prototype through...

2010-12-08 07:03:00

CULVER CITY, Calif., Dec. 8, 2010 /PRNewswire/ -- Sofie Biosciences, a developer of agents and devices for the molecular imaging of disease, announced today the closing of an additional $2 million from new and existing investors. Funds will be used for the development of new PET imaging agents and for enhancements to their PET imaging systems and chemistry units. The round includes the first institutional and large corporate financing to the firm including investment by the Cycad Group....

2010-12-02 00:00:47

PlanClear, the nuclear medicine industry's premier Growth Management firm, has finalized and issued its performance report for the 2010 3rd Qtr and (partial) 4th Qtr accomplishments of industry leader Positron (POSC). The PlanClear report highlighted the accomplishment of three critical benchmarks: 1) Sale of 15 PET Camera systems within one year after receiving FDA approval, 2) Eliminating debt and strengthening the POSC balance sheet, and 3) Successful R&D efforts resulting in a new...

2010-11-28 08:00:00

CHICAGO, Nov. 28, 2010 /PRNewswire/ -- This year at the 96th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Royal Philips Electronics (NYSE: PHG, AEX: PHI) is ushering in a new era in radiology science with Imaging 2.0, a concept fueled by integration of technology, clinician and patient. Showcasing its commitment to pioneering innovative, cost-effective solutions, Philips is highlighting technologies that focus specifically on the patient, in addition to...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related